Microneedling Mesotherapy (Dermica Pen)

Top Laser Olomouc's microneedling mesotherapy service uses the Dermica Pen — a Swiss-made high-frequency dermapen device — to deliver active serums directly into the dermis at precisely controlled needle depth. The Paskin 31-gauge applicator creates uniform micro-channels through which the clinic's chosen active — RRS Hyalift 75 Pro, a professional hyaluronic acid and peptide complex — is introduced, maximising absorption far beyond topical application. The treatment addresses facial rejuvenation, fine line correction, acne, hair growth stimulation on the scalp, and localised fat reduction on the chin and arms. Unlike ablative laser procedures, there is no visible peeling or prolonged downtime: most patients return to work the following day. The combination of controlled micro-injury stimulus and serum delivery makes this one of the clinic's most versatile skin quality treatments.

The Dermica Pen used at Top Laser Olomouc is manufactured in Switzerland, reflecting the clinic's preference for medically validated instruments. Dermapen devices operate by oscillating a cartridge of ultra-fine needles at high frequency — the Dermica Pen achieves consistent penetration depth with minimal lateral tissue drag, important for patient comfort and for maintaining needle sterility across the full treatment area. The Paskin 31-gauge applicator is one of the finest available, reducing epidermal trauma while still creating the microchannels needed for efficient active delivery. The primary serum used — RRS Hyalift 75 Pro — contains high-molecular-weight hyaluronic acid for immediate surface hydration combined with low-molecular-weight HA fragments that penetrate to the mid-dermis, alongside amino acids, vitamins, and peptides that support fibroblast function and collagen synthesis. Patients who prefer an alternative active can discuss their options at consultation. During the session, a topical numbing cream is applied 20–30 minutes before treatment. The Dermica Pen is then moved systematically across the treatment zone in overlapping vertical, horizontal, and diagonal passes at the depth preset for the indication: shallower settings (0.25–0.5 mm) for pure serum delivery and superficial rejuvenation, medium settings (0.5–1.5 mm) for collagen induction therapy targeting scars or hair loss, and deeper settings (1.5–2.5 mm) for more established scarring. The micro-injury response triggers platelets and growth factors at the treatment site, and the cascade of collagen and elastin production continues for weeks to months after each session. Scalp treatment for hair growth uses a targeted Dermica Pen protocol combined with hair-specific actives, stimulating dermal papilla cells and follicular blood supply. For localised chin and arm fat reduction, the pen introduces lipolytic actives via the same micro-channelling principle. A typical treatment takes 30–45 minutes for the face; scalp and body areas vary. Post-treatment redness resolves within 12–24 hours in most patients. A series of four to six sessions spaced three to four weeks apart is recommended for sustained skin quality improvement, with a maintenance session every three to four months.